Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.
Boy
Mary G
MG
Wang
Cunshan
C
Wilkinson
Bethanie E
BE
Chow
Vincent Fung-Sing
VF
Clucas
Alan T
AT
Krueger
James G
JG
Gaweco
Anderson S
AS
Zwillich
Samuel H
SH
Changelian
Paul S
PS
Chan
Gary
G
D000328:Adult; D001706:Biopsy; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D010880:Piperidines; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use*
D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib